NIKA PHARMACEUTICALS, INC - 13 Apr 2022 Form 4 Insider Report for NIKA PHARMACEUTICALS, INC (NIKA)

Reporting relationship: President, CEO, CFO, Director, 10%+ Owner
Issuer ticker: NIKA
Reported as of: 13 Apr 2022
Net transaction value: +$29,999,999,727,868
SEC form: 4
Accepted by SEC: 19 Mar 2024, 14:08:45 UTC
Next SEC filing: 19 Mar 2024
Source filing: View source filing
Reporting owner signature: Savov Dimitar Slavchev

Key filing fact

NIKA PHARMACEUTICALS, INC filed Form 4 for NIKA PHARMACEUTICALS, INC (NIKA) on 19 Mar 2024.

Key facts

This page summarizes NIKA PHARMACEUTICALS, INC's Form 4 filing for NIKA PHARMACEUTICALS, INC (NIKA).
9 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Mar 2024, 14:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$29,999,999,727,868.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NKPH transaction

Preferred A Stock

Other

Transaction value: $30,000,000,000,000
Shares: +10,000,000
Change %
Price: $3000000.00^*
Shares after: 10,000,000
Date: 13 Apr 2022
Ownership: Direct
Footnotes: F1, F2

NKPH transaction

Common

Purchase

Transaction value: $137,868
Shares: +11,489,000
Change %
Price: $0.0120^*
Shares after: $11,489,000
Date: 13 Apr 2022
Ownership: Direct

NKPH transaction

Common

Other

Transaction value: $0
Shares: +333,181,000
Change %
Price: $0.000000
Shares after: $344,670,000
Date: 20 Jul 2022
Ownership: Direct
Footnotes: F3

NKPH transaction

Common

Sale

Transaction value: $140,000
Shares: -7,000,000
Change %
Price: $0.0200^*
Shares after: $337,670,000
Date: 12 Sep 2022
Ownership: Direct

NKPH transaction

Common

Sale

Transaction value: $25,000
Shares: -1,250,000
Change %
Price: $0.0200^*
Shares after: $336,420,000
Date: 26 Sep 2022
Ownership: Direct

NKPH transaction

Common

Sale

Transaction value: $111,000
Shares: -3,000,000
Change %
Price: $0.0370^*
Shares after: $333,420,000
Date: 24 Oct 2022
Ownership: Direct

NKPH transaction

Common

Sale

Transaction value: $63,000
Shares: -6,300,000
Change %
Price: $0.0100^*
Shares after: $327,120,000
Date: 10 Jan 2023
Ownership: Direct

NKPH transaction

Common

Sale

Transaction value: $15,000
Shares: -1,500,000
Change %
Price: $0.0100^*
Shares after: $325,620,000
Date: 31 Jan 2023
Ownership: Direct

NKPH transaction

Common

Sale

Transaction value: $56,000
Shares: -3,500,000
Change %
Price: $0.0160^*
Shares after: $322,120,000
Date: 02 Jun 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Issuance per terms of Exclusive Rights Agreement

Footnote F2

Exclusive rights valued at 3,000,000

Footnote F3

30-1 forward split as dividend